_id

6918540c3c536f8df231788c

Ticker

0A9G.LSE

Name

Mereo BioPharma Group PLC ADR

Exchange

LSE

Address

One Cavendish Place, London, United Kingdom, W1G 0QF

Country

UK

Sector

Industry

Currency

USD

Website

https://www.mereobiopharma.com

Description

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab, an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for use in the treatment of tumors. The company is also developing Navicixizumab, which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod, a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole, an oral aromatase inhibitor, which is in Phase 2 trials for use in the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab, an antibody for the treatment of osteogenesis imperfecta; and Alvelestat, an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; and licensing agreement with AstraZeneca. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, United Kingdom.

Last Close

0.41

Volume

27257

Current Price

0.4047

Change

0.0109

Last Updated

2026-01-08T13:31:41.472Z

Image

https://logo.clearbit.com/www.mereobiopharma.com

Ipo Date

-

Market Cap

-

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2023-06-30

Revenue

-

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

-

Operating Income

-

Interest Expense

-

Pretax Income

-

Net Income

-

Eps

-

Dividends Per Share

-

Shares Outstanding

0

Income Tax Expense

-453500

EBITDA

-

Operating Margin

-

Total Other Income Expense Net

-

Cash

-

Short Term Investments

-

Receivables

10739000

Inventories

-

Total Current Assets

54228000

Property Plant Equipment

1565000

Total Assets

-

Payables

1911000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

17458000

Equity

-

Bs_currency_symbol

GBP

Depreciation

133000

Change In Working Capital

-

Cash From Operations

-6631000

Capital Expenditures

0

Cash From Investing

65500

Cash From Financing

-458000

Net Change In Cash

-7110500

Cf_currency_symbol

USD

PE

-

PB

-

ROE

-

ROA

-

FCF

-6631000

Fcf Percent

-

Piotroski FScore

0

Health Score

45

Deep Value Investing Score

0

Defensive Investing Score

5

Dividend Investing Score

1.5

Economic Moat Investing Score

1

Garp Investing Score

0

Growth Investing Score

0

Momentum Investing Score

2

Net Net Investing Score

0

Quality Investing Score

0

Value Investing Score

1.5

Quarters > 0 > quarter

2023-06-30

Quarters > 0 > income Statement > revenue

-

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

-

Quarters > 0 > income Statement > operating Income

-

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-

Quarters > 0 > income Statement > net Income

-

Quarters > 0 > income Statement > eps

-

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

-

Quarters > 0 > income Statement > income Tax Expense

-453500

Quarters > 0 > income Statement > EBITDA

-

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

-

Quarters > 0 > income Statement > currency_symbol

GBP

Quarters > 0 > balance Sheet > cash

-

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

10739000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

54228000

Quarters > 0 > balance Sheet > property Plant Equipment

1565000

Quarters > 0 > balance Sheet > total Assets

-

Quarters > 0 > balance Sheet > payables

1911000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

17458000

Quarters > 0 > balance Sheet > equity

-

Quarters > 0 > balance Sheet > currency_symbol

GBP

Quarters > 0 > cash Flow > net Income

-5515000

Quarters > 0 > cash Flow > depreciation

133000

Quarters > 0 > cash Flow > change In Working Capital

-

Quarters > 0 > cash Flow > cash From Operations

-6631000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

65500

Quarters > 0 > cash Flow > cash From Financing

-458000

Quarters > 0 > cash Flow > net Change In Cash

-7110500

Quarters > 0 > cash Flow > currency_symbol

USD

Quarters > 0 > ratios > PE

-

Quarters > 0 > ratios > PB

-

Quarters > 0 > ratios > ROE

-

Quarters > 0 > ratios > ROA

-

Quarters > 0 > ratios > FCF

-6631000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

45

Quarters > 1 > quarter

2023-03-31

Quarters > 1 > income Statement > revenue

-

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

-

Quarters > 1 > income Statement > operating Income

-

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-

Quarters > 1 > income Statement > net Income

-

Quarters > 1 > income Statement > eps

-

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

-

Quarters > 1 > income Statement > income Tax Expense

-453500

Quarters > 1 > income Statement > EBITDA

-

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

-

Quarters > 1 > income Statement > currency_symbol

GBP

Quarters > 1 > balance Sheet > cash

-

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

10739000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

54228000

Quarters > 1 > balance Sheet > property Plant Equipment

1565000

Quarters > 1 > balance Sheet > total Assets

-

Quarters > 1 > balance Sheet > payables

1911000

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

17458000

Quarters > 1 > balance Sheet > equity

-

Quarters > 1 > balance Sheet > currency_symbol

GBP

Quarters > 1 > cash Flow > net Income

-5515000

Quarters > 1 > cash Flow > depreciation

133000

Quarters > 1 > cash Flow > change In Working Capital

-

Quarters > 1 > cash Flow > cash From Operations

-6631000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

65500

Quarters > 1 > cash Flow > cash From Financing

-458000

Quarters > 1 > cash Flow > net Change In Cash

-7110500

Quarters > 1 > cash Flow > currency_symbol

GBP

Quarters > 1 > ratios > PE

-

Quarters > 1 > ratios > PB

-

Quarters > 1 > ratios > ROE

-

Quarters > 1 > ratios > ROA

-

Quarters > 1 > ratios > FCF

-6631000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

45

Quarters > 2 > quarter

2022-12-31

Quarters > 2 > income Statement > revenue

-

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

-

Quarters > 2 > income Statement > operating Income

-

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-

Quarters > 2 > income Statement > net Income

-

Quarters > 2 > income Statement > eps

-

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

-

Quarters > 2 > income Statement > income Tax Expense

-581000

Quarters > 2 > income Statement > EBITDA

-

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

-

Quarters > 2 > income Statement > currency_symbol

GBP

Quarters > 2 > balance Sheet > cash

-

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

2379000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

-

Quarters > 2 > balance Sheet > property Plant Equipment

-

Quarters > 2 > balance Sheet > total Assets

-

Quarters > 2 > balance Sheet > payables

2886000

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

24677000

Quarters > 2 > balance Sheet > equity

-

Quarters > 2 > balance Sheet > currency_symbol

GBP

Quarters > 2 > cash Flow > net Income

-7519000

Quarters > 2 > cash Flow > depreciation

145500

Quarters > 2 > cash Flow > change In Working Capital

-

Quarters > 2 > cash Flow > cash From Operations

-6631000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

261500

Quarters > 2 > cash Flow > cash From Financing

-246000

Quarters > 2 > cash Flow > net Change In Cash

-10040500

Quarters > 2 > cash Flow > currency_symbol

GBP

Quarters > 2 > ratios > PE

-

Quarters > 2 > ratios > PB

-

Quarters > 2 > ratios > ROE

-

Quarters > 2 > ratios > ROA

-

Quarters > 2 > ratios > FCF

-6631000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

45

Quarters > 3 > quarter

2022-09-30

Quarters > 3 > income Statement > revenue

-

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

-

Quarters > 3 > income Statement > operating Income

-

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-

Quarters > 3 > income Statement > net Income

-

Quarters > 3 > income Statement > eps

-

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

-

Quarters > 3 > income Statement > income Tax Expense

-581000

Quarters > 3 > income Statement > EBITDA

-

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

-

Quarters > 3 > income Statement > currency_symbol

GBP

Quarters > 3 > balance Sheet > cash

-

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

62131000

Quarters > 3 > balance Sheet > property Plant Equipment

-

Quarters > 3 > balance Sheet > total Assets

-

Quarters > 3 > balance Sheet > payables

-

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

24677000

Quarters > 3 > balance Sheet > equity

-

Quarters > 3 > balance Sheet > currency_symbol

GBP

Quarters > 3 > cash Flow > net Income

-7519000

Quarters > 3 > cash Flow > depreciation

145500

Quarters > 3 > cash Flow > change In Working Capital

-

Quarters > 3 > cash Flow > cash From Operations

-6631000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

261500

Quarters > 3 > cash Flow > cash From Financing

-246000

Quarters > 3 > cash Flow > net Change In Cash

-10040500

Quarters > 3 > cash Flow > currency_symbol

GBP

Quarters > 3 > ratios > PE

-

Quarters > 3 > ratios > PB

-

Quarters > 3 > ratios > ROE

-

Quarters > 3 > ratios > ROA

-

Quarters > 3 > ratios > FCF

-6631000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

45

Annuals > 0 > quarter

2022-12-31

Annuals > 0 > income Statement > revenue

-

Annuals > 0 > income Statement > cost Of Revenue

-

Annuals > 0 > income Statement > gross Profit

-

Annuals > 0 > income Statement > operating Expenses

-

Annuals > 0 > income Statement > operating Income

-

Annuals > 0 > income Statement > interest Expense

-

Annuals > 0 > income Statement > pretax Income

-

Annuals > 0 > income Statement > net Income

-

Annuals > 0 > income Statement > eps

-

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

-

Annuals > 0 > income Statement > income Tax Expense

-1897000

Annuals > 0 > income Statement > EBITDA

-

Annuals > 0 > income Statement > operating Margin

-

Annuals > 0 > income Statement > total Other Income Expense Net

-

Annuals > 0 > income Statement > currency_symbol

GBP

Annuals > 0 > balance Sheet > cash

-

Annuals > 0 > balance Sheet > short Term Investments

-

Annuals > 0 > balance Sheet > receivables

-

Annuals > 0 > balance Sheet > inventories

-

Annuals > 0 > balance Sheet > total Current Assets

62131000

Annuals > 0 > balance Sheet > property Plant Equipment

1831000

Annuals > 0 > balance Sheet > total Assets

-

Annuals > 0 > balance Sheet > payables

2886000

Annuals > 0 > balance Sheet > short Term Debt

-

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

24677000

Annuals > 0 > balance Sheet > equity

-

Annuals > 0 > balance Sheet > currency_symbol

GBP

Annuals > 0 > cash Flow > net Income

-34196000

Annuals > 0 > cash Flow > depreciation

727000

Annuals > 0 > cash Flow > change In Working Capital

-

Annuals > 0 > cash Flow > cash From Operations

-38820000

Annuals > 0 > cash Flow > capital Expenditures

10000

Annuals > 0 > cash Flow > cash From Investing

-

Annuals > 0 > cash Flow > cash From Financing

-784000

Annuals > 0 > cash Flow > net Change In Cash

-37962000

Annuals > 0 > cash Flow > currency_symbol

USD

Annuals > 0 > ratios > PE

-

Annuals > 0 > ratios > PB

-

Annuals > 0 > ratios > ROE

-

Annuals > 0 > ratios > ROA

-

Annuals > 0 > ratios > FCF

-38830000

Annuals > 0 > ratios > Piotroski FScore

0

Annuals > 0 > ratios > fcf Percent

-

Annuals > 0 > health Score

45

Annuals > 1 > quarter

2021-12-31

Annuals > 1 > income Statement > revenue

-

Annuals > 1 > income Statement > cost Of Revenue

-

Annuals > 1 > income Statement > gross Profit

-

Annuals > 1 > income Statement > operating Expenses

-

Annuals > 1 > income Statement > operating Income

-

Annuals > 1 > income Statement > interest Expense

-

Annuals > 1 > income Statement > pretax Income

-

Annuals > 1 > income Statement > net Income

-

Annuals > 1 > income Statement > eps

-

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

-

Annuals > 1 > income Statement > income Tax Expense

1516000

Annuals > 1 > income Statement > EBITDA

-

Annuals > 1 > income Statement > operating Margin

-

Annuals > 1 > income Statement > total Other Income Expense Net

-

Annuals > 1 > income Statement > currency_symbol

GBP

Annuals > 1 > balance Sheet > cash

-

Annuals > 1 > balance Sheet > short Term Investments

-

Annuals > 1 > balance Sheet > receivables

1820000

Annuals > 1 > balance Sheet > inventories

-

Annuals > 1 > balance Sheet > total Current Assets

99323000

Annuals > 1 > balance Sheet > property Plant Equipment

2530000

Annuals > 1 > balance Sheet > total Assets

-

Annuals > 1 > balance Sheet > payables

2285000

Annuals > 1 > balance Sheet > short Term Debt

-

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

12541000

Annuals > 1 > balance Sheet > equity

-

Annuals > 1 > balance Sheet > currency_symbol

GBP

Annuals > 1 > cash Flow > net Income

12725000

Annuals > 1 > cash Flow > depreciation

642000

Annuals > 1 > cash Flow > change In Working Capital

-

Annuals > 1 > cash Flow > cash From Operations

-5239000

Annuals > 1 > cash Flow > capital Expenditures

535000

Annuals > 1 > cash Flow > cash From Investing

-421000

Annuals > 1 > cash Flow > cash From Financing

77652000

Annuals > 1 > cash Flow > net Change In Cash

70827000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

-

Annuals > 1 > ratios > PB

-

Annuals > 1 > ratios > ROE

-

Annuals > 1 > ratios > ROA

-

Annuals > 1 > ratios > FCF

-5774000

Annuals > 1 > ratios > Piotroski FScore

0

Annuals > 1 > ratios > fcf Percent

-

Annuals > 1 > health Score

45

Annuals > 2 > quarter

2020-12-31

Annuals > 2 > income Statement > revenue

-

Annuals > 2 > income Statement > cost Of Revenue

-

Annuals > 2 > income Statement > gross Profit

-

Annuals > 2 > income Statement > operating Expenses

-

Annuals > 2 > income Statement > operating Income

-

Annuals > 2 > income Statement > interest Expense

-

Annuals > 2 > income Statement > pretax Income

-

Annuals > 2 > income Statement > net Income

-

Annuals > 2 > income Statement > eps

-

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

-

Annuals > 2 > income Statement > income Tax Expense

-2822000

Annuals > 2 > income Statement > EBITDA

-

Annuals > 2 > income Statement > operating Margin

-

Annuals > 2 > income Statement > total Other Income Expense Net

-

Annuals > 2 > income Statement > currency_symbol

GBP

Annuals > 2 > balance Sheet > cash

-

Annuals > 2 > balance Sheet > short Term Investments

-

Annuals > 2 > balance Sheet > receivables

4231000

Annuals > 2 > balance Sheet > inventories

-

Annuals > 2 > balance Sheet > total Current Assets

29726000

Annuals > 2 > balance Sheet > property Plant Equipment

1573000

Annuals > 2 > balance Sheet > total Assets

-

Annuals > 2 > balance Sheet > payables

3165000

Annuals > 2 > balance Sheet > short Term Debt

-

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

8565000

Annuals > 2 > balance Sheet > equity

-

Annuals > 2 > balance Sheet > currency_symbol

GBP

Annuals > 2 > cash Flow > net Income

-163628000

Annuals > 2 > cash Flow > depreciation

1599000

Annuals > 2 > cash Flow > change In Working Capital

-

Annuals > 2 > cash Flow > cash From Operations

-28341000

Annuals > 2 > cash Flow > capital Expenditures

16000

Annuals > 2 > cash Flow > cash From Investing

1495000

Annuals > 2 > cash Flow > cash From Financing

34737000

Annuals > 2 > cash Flow > net Change In Cash

7122000

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

-

Annuals > 2 > ratios > PB

-

Annuals > 2 > ratios > ROE

-

Annuals > 2 > ratios > ROA

-

Annuals > 2 > ratios > FCF

-28357000

Annuals > 2 > ratios > Piotroski FScore

0

Annuals > 2 > ratios > fcf Percent

-

Annuals > 2 > health Score

45

Annuals > 3 > quarter

2019-12-31

Annuals > 3 > income Statement > revenue

-

Annuals > 3 > income Statement > cost Of Revenue

-

Annuals > 3 > income Statement > gross Profit

-

Annuals > 3 > income Statement > operating Expenses

-

Annuals > 3 > income Statement > operating Income

-

Annuals > 3 > income Statement > interest Expense

-

Annuals > 3 > income Statement > pretax Income

-

Annuals > 3 > income Statement > net Income

-

Annuals > 3 > income Statement > eps

-

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

-

Annuals > 3 > income Statement > income Tax Expense

-6274000

Annuals > 3 > income Statement > EBITDA

-

Annuals > 3 > income Statement > operating Margin

-

Annuals > 3 > income Statement > total Other Income Expense Net

-

Annuals > 3 > income Statement > currency_symbol

GBP

Annuals > 3 > balance Sheet > cash

-

Annuals > 3 > balance Sheet > short Term Investments

-

Annuals > 3 > balance Sheet > receivables

11684000

Annuals > 3 > balance Sheet > inventories

-

Annuals > 3 > balance Sheet > total Current Assets

30435000

Annuals > 3 > balance Sheet > property Plant Equipment

11558000

Annuals > 3 > balance Sheet > total Assets

-

Annuals > 3 > balance Sheet > payables

6148000

Annuals > 3 > balance Sheet > short Term Debt

-

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

29878000

Annuals > 3 > balance Sheet > equity

-

Annuals > 3 > balance Sheet > currency_symbol

GBP

Annuals > 3 > cash Flow > net Income

-34844000

Annuals > 3 > cash Flow > depreciation

1577000

Annuals > 3 > cash Flow > change In Working Capital

-

Annuals > 3 > cash Flow > cash From Operations

-45931000

Annuals > 3 > cash Flow > capital Expenditures

21000

Annuals > 3 > cash Flow > cash From Investing

43295000

Annuals > 3 > cash Flow > cash From Financing

-5710000

Annuals > 3 > cash Flow > net Change In Cash

-8695000

Annuals > 3 > cash Flow > currency_symbol

GBP

Annuals > 3 > ratios > PE

-

Annuals > 3 > ratios > PB

-

Annuals > 3 > ratios > ROE

-

Annuals > 3 > ratios > ROA

-

Annuals > 3 > ratios > FCF

-45952000

Annuals > 3 > ratios > Piotroski FScore

0

Annuals > 3 > ratios > fcf Percent

-

Annuals > 3 > health Score

45

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > final Score

50

Profitability > verdict

Weak

Risk > final Score

50

Risk > verdict

High

Liquidity > metrics > Current Ratio

28.376766091051806

Liquidity > metrics > Quick Ratio

28.376766091051806

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

50

Prev Profitabilities > 1

50

Prev Profitabilities > 2

50

Prev Risks > 0

50

Prev Risks > 1

50

Prev Risks > 2

50

Prev Liquidities > 0

100

Prev Liquidities > 1

10

Prev Liquidities > 2

50

Updated At

2026-01-20T22:52:12.628Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-03-25

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

AfterMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

-0.01

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-